Starcoin - Co与领航医药生物科技修订可转换债券条款,将可转换债券金额调整至10亿港元
Starcoin - Co与领航医药生物科技修订可转换债券条款,将可转换债券金额调整至10亿港元
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.